Transplantation has traditionally been the primary method for replacing the body’s damaged and ill parts. Nevertheless, the complete reliance on transplantation has resulted in a waiting list of persons needing donated tissues and organs, and in general, supply cannot meet demand. The cost to society in terms of caring for patients with failing organs and debilitating diseases is enormous. Unfortunately, the need for new tissues is likely to increase, given the global rise of the aging population and chronic diseases. Due to the lack of adequate supplies of tissues and organs, companies like Cells for Cells have been developing biomaterial-based solutions that can replace damaged tissues and promote the creation of entirely new biological structures by the patient’s own body.
Tissue Engineering & Biomaterials
The concept of engineering structures by combining biomaterial scaffolds, cells, and even growth factors through novel biofabrication methods is called tissue engineering. It is a highly interdisciplinary field, drawing ideas from biology, chemistry, materials science, engineering, medicine, and many other areas with the vision of regenerating whole organs or tissues. Tissue engineering can be used to construct various tissues, including blood vessels, nerve tissue, skin, cartilage, and bones. Mainly, Cells for Cells has focused its resources on developing tissue-engineered solutions for cardiovascular (Veintis™) and orthopedics (Inkure®Cartilage) indications, two of the highest-growing markets in terms of patients and revenue prospects. The impact and sophistication of the products designed and validated by Cells for Cells’ Tissue Engineering and Biofabrication Unit earned the team the Avonni Prize, Chile’s National Innovation Prize, in 2020.
Pipeline
